Search results for " natural history"

showing 10 items of 16 documents

AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions

2017

Abstract This review summarizes our current understanding of nonalcoholic fatty liver disease (NAFLD), a multi-factorial systemic disease resulting from a complex interaction between a specific genetic background and multiple environmental/metabolic “hits”. The role of gut microbiota, lipotoxicity, inflammation and their molecular pathways is reviewed in-depth. We also discuss the epidemiology and natural history of NAFLD by pinpointing the remarkably high prevalence of NAFLD worldwide and its inherent systemic complications: hepatic (steatohepatitis, advanced fibrosis and cirrhosis), cardio-metabolic (cardiovascular disease, cardiomyopathy, arrhythmias and type 2 diabetes) and neoplastic (…

0301 basic medicineDiagnostic ImagingLiver Cirrhosismedicine.medical_specialtyCirrhosisEpidemiologySettore MED/12 - GASTROENTEROLOGIAPhysiopathologyNatural historyType 2 diabetesDiseaseDiagnosis; Epidemiology; Genetics; Management; Natural history; PhysiopathologyBioinformaticsGastroenterology03 medical and health sciences0302 clinical medicineGeneticNon-alcoholic Fatty Liver DiseaseInternal medicineNonalcoholic fatty liver diseaseDiagnosismedicineGeneticsHumansmedicine.diagnostic_testHepatologyDiagnosis; Epidemiology; Genetics; Management; Natural history; Physiopathology; Hepatology; Gastroenterologybusiness.industryLiver NeoplasmsGastroenterologyHepatologymedicine.diseaseManagement030104 developmental biologyLipotoxicityDiabetes Mellitus Type 2LiverCardiovascular DiseasesLiver biopsy030211 gastroenterology & hepatologySteatohepatitisbusinessBiomarkersDiagnosi
researchProduct

Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort

2016

Background: Natural history of primary biliary cirrhosis (PBC) is partially characterized in patients from the Mediterranean area whose genetic background differs from that of Northern Europeans. Objectives: We aimed to describe genetic susceptibility and clinical course of PBC in patients from Southern Italy. Methods: Socio-demographic, clinical, biochemical and histological data at diagnosis as well as disease progression of 81 PBC consecutive patients were collected. All subjects were treated with Ursodeoxycholic acid at a dose of 15 mg/kg. HLA class II DRB1 alleles were compared with those of 237 healthy control subjects. IL28B genotyping for IL28B rs12979860 C/T and rs80899917 G/T was …

0301 basic medicinemedicine.medical_specialtyPrimary biliary cirrhosimedicine.medical_treatmentLiver transplantationGastroenterology03 medical and health sciences0302 clinical medicinePrimary biliary cirrhosisGeneticInternal medicineGenotypemedicineGenetic predispositionProspective cohort studySettore MED/04 - Patologia GeneraleAutoimmune diseaseSettore MED/12 - GastroenterologiaPrimary Biliary CirrhosisHepatologybusiness.industrymedicine.diseaseKowsarTransplantation030104 developmental biologyInfectious DiseasesGenetic; Natural history; Primary biliary cirrhosis; Hepatology; Infectious Diseases030211 gastroenterology & hepatologybusinessResearch ArticleNatural HistoryHepatitis Monthly
researchProduct

Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study

2009

OBJECTIVES: The identification of prognostic factors associated with mortality is crucial in any clinical setting. METHODS: We enrolled in a prospective study 352 patients with compensated hepatitis C virus (HCV)-induced cirrhosis, consecutively observed between 1989 and 1992. At entry, patients underwent upper endoscopy to detect esophageal varices, and were then surveilled by serial clinical and ultrasonographic examination. The model for end-stage liver disease (MELD) score was calculated with information collected at enrollment. Baseline predictors and intercurrent events associated with mortality were assessed using the Cox regression model. RESULTS: During a median follow-up of 14.4 y…

AdultLiver CirrhosisMalemedicine.medical_specialtyTime FactorsCirrhosisBiopsy Fine-NeedleKaplan-Meier EstimateEsophageal and Gastric VaricesAntiviral AgentsRisk AssessmentSeverity of Illness IndexGastroenterologyCohort StudiesPredictive Value of TestsCause of DeathInternal medicineEpidemiologyConfidence IntervalsmedicineHumansProspective StudiesRisk factorProspective cohort studyAgedProbabilityProportional Hazards ModelsCause of deathSettore MED/12 - GastroenterologiaHepatologybusiness.industryGastroenterologyInterferon-alphavirus diseasesHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseImmunohistochemistrySurvival Analysisliver cirrhosis natural historyDisease ProgressionFemalebusinessRisk assessmentLiver FailureFollow-Up StudiesCohort studyThe American Journal of Gastroenterology
researchProduct

The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection

2010

Natural history of HCV related chronic hepatitis is influenced and modified by many factors: virus features, coinfections and host characteristics. In particular, a peculiar genetic background of the host by conditioning the occurrence of intracellular metabolic derangements (i.e., insulin resistance) might contribute to accelerate the rate of progression to cirrhosis and eventually the occurrence of hepatocellular carcinoma (HCC) and death. Likely, direct interplays between virus genotype and host genetic background might be hypothesized at this level. Morbidity and mortality in cirrhosis is primarily associated with complications of liver cirrhosis (ascites, hepatic encephalopathy, jaundi…

CirrhosisHepatologybusiness.industryReview ArticleJaundicemedicine.diseaseVirusdigestive system diseasesHCV therapy natural historyInsulin resistanceInterferonHepatocellular carcinomaImmunologyAscitesmedicinelcsh:Diseases of the digestive system. Gastroenterologymedicine.symptomlcsh:RC799-869businessHepatic encephalopathymedicine.drugInternational Journal of Hepatology
researchProduct

"Paolo Boccone’s curious observations and the Commitment to Visual Communication of Natural History", speech at International Conference "Art and Sci…

2015

In his "Recherches et observations naturelles" (Amsterdam 1674) the botanist Paolo Boccone (1633- 1704) presents himself as an advocate of a new visual method. He was supported by Jan Swammerdam, with whom he shared his scientific observations. Boccone claims to be the first to apply microscopic dissection to figured stones, in order to distinguish accidental shapes from natural ones. Boccone, as many of the members of the scientific community with whom he corresponded, had a strong commitment to painstaking observation and visual communication, that he was able to handle on many levels. The allegorical frontispiece of "Recherches" is aimed to present a range of moral and psychological atti…

History of Science Visual Cultures of Science (Visual Studies) Natural history collections Nature prints
researchProduct

A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses

2014

Background: Coeliac disease is a common enteropathy characterized by an increased mortality mainly due to its complications. The natural history of complicated coeliac disease is characterised by two different types of course: patients with a new diagnosis of coeliac disease that do not improve despite a strict gluten-free diet (type A cases) and previously diagnosed coeliac patients that initially improved on a gluten-free diet but then relapsed despite a strict diet (type B cases). Our aim was to study the prognosis and survival of A and B cases. Methods: Clinical and laboratory data from coeliac patients who later developed complications (A and B cases) and sex- and age-matched coeliac p…

MaleComplicationsSettore MED/09 - Medicina InternaLymphomaSmallGastroenterologyCoeliac diseaseEnteropathy-Associated T-Cell LymphomaIntestine SmallMedicineCeliac diseaseEnteropathyTreatment FailureINTESTINAL T-CELL LYMPHOMAGastroenterologyGLUTEN FREE DIETGeneral Medicinecomplicated coeliac disease; natural history; prognosis;IleitisMiddle AgedPrognosisEnteritisIntestineNatural historyAdult; Aged; Carcinoma; Case-Control Studies; Celiac Disease; Collagenous Sprue; Disease Progression; Enteritis; Enteropathy-Associated T-Cell Lymphoma; Female; Humans; Ileitis; Intestinal Neoplasms; Intestine Small; Jejunal Diseases; Lymphoma B-Cell; Male; Middle Aged; Prognosis; Treatment Failure; Diet Gluten-Freenatural historyGluten-free dietDisease ProgressionEnteropathy-associated T-cell lymphomaFemaleprognosiResearch ArticleCollagenous SprueAdultmedicine.medical_specialtyLymphoma B-CellGlutensSettore MED/12 - GASTROENTEROLOGIAcomplicated coeliac diseasecomplications/drug therapy/mortality Myocytes; celiac diseaseNODiet Gluten-FreeInternal medicineIntestinal NeoplasmsHumanscomplications/drug therapy/mortalitySurvival rateCELIAC DISEASE; Complications; INTESTINAL T-CELL LYMPHOMA; prognosis; GLUTEN FREE DIETAgedcomplications/drug therapy/mortality; Myocytes; celiac diseaseMyocytesbusiness.industryCarcinomaB-CellCase-control studynutritional and metabolic diseasesJejunal DiseasesHepatologymedicine.diseasedigestive system diseasesDietEATLCase-Control StudiesGluten-FreeGluten freebusinessComplicationcoeliac disease
researchProduct

Management of chronic hepatitis C in childhood: The impact of therapy in the clinical practice during the first 2 decades

2011

Background and aim: Treatment of chronic hepatitis C in children is controversial and its role in the clinical practice is unknown. We retrospectively investigated the impact of treatment in a large cohort of children with chronic hepatitis C over the past 20years. Methods: 376 hepatitis C virus RNApositive children were recruited consecutively in five Italian centres since 1990and followed for1–17years. Results: 86 (23%)subjects were treated: 73 with recombinant interferon alone and 13 with pegylated-interferon and ribavirin. Sustained clearance of hepatitis C virus RNA was observed in 25%of the former, in 92%of the latter and in 9% of untreated cases(p < 0.001). Loss of viraemia was re…

Malemedicine.medical_specialtyAdolescentGenotypeCombination therapyHepatitis C virusNatural historyCHILDRENHepacivirusInterferon alpha-2medicine.disease_causeAntiviral AgentsTHERAPYPolyethylene Glycolschemistry.chemical_compoundChronic hepatitisHepatitis C virus RNAInternal medicineRibavirinmedicineHumansChildRetrospective StudiesHepatologyHepatitis C virusbusiness.industryRibavirinGastroenterologyInfantInterferon-alphaCHRONIC HEPATITISHepatitis C ChronicRecombinant ProteinsTreatmentNatural historyClinical PracticeSustained virological responseChildren; Hepatitis C virus; Natural history; Sustained virological response; TreatmentchemistryViral replicationChild PreschoolHCVImmunologyRNA ViralDrug Therapy CombinationFemaleInterferonsbusinessDigestive and Liver Disease
researchProduct

The Alloxysta (Hymenoptera: Figitidae: Charipinae) type material in the United States National Museum of Natural History and the Canadian National Co…

2013

AbstractAlloxysta Förster, 1869 (Hymenoptera: Figitidae) type material of 19 nominal species deposited in the Canadian National Collection of Insects (Ottawa, Ontario, Canada) and the United States National Museum of Natural History (Washington, District of Columbia, United States of America) were studied. Nine species are treated as valid: A. australiae (Ashmead, 1900), A. commensuratus Andrews, 1978, A. japonicus (Ashmead, 1904), A. lachni (Ashmead, 1885), A. longiventris Baker, 1896, A. minuscula Andrews, 1978, A. nothofagi Andrews, 1976, A. vandenboschi Andrews, 1978, and A. xanthopsis (Ashmead, 1896). The following synonymies are established: A. affinis (Baker, 1896) and A. quebeci And…

National Museum of Natural HistoryCharipinaeType (biology)biologyPhysiologyStructural BiologyInsect ScienceZoologyFigitidaeHymenopterabiology.organism_classificationMolecular BiologyEcology Evolution Behavior and SystematicsThe Canadian Entomologist
researchProduct

A new species of the genus Cyclopelta (Hemiptera: Dinidoridae) from Thailand, with a key to its Oriental species

2013

Cyclopelta gibbosasp. nov., a new species of dinidorid bug is described from Thailand and compared with Cyclopelta obscura. It is the ninth Oriental species of the genus, and the fourth known species from Thailand. A key to all the Oriental species of the genus Cyclopelta is also provided. The type specimens are deposited with the Smithsonian National Museum of Natural History, Washington, USA, and the Department of Biosystematics, Opole University, Poland.

National Museum of Natural HistoryType (biology)DinidoridaebiologyGenusInsect ScienceHeteropteraZoologyKey (lock)biology.organism_classificationCyclopeltaHemipteraOriental Insects
researchProduct

Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study

2012

Abstract AIM: To investigate the clinical course of untreatable hepatocellular carcinoma (HCC) identified at any stage and to identify factors associated with mortality. METHODS: From January 1999 to December 2010, 320 out of 825 consecutive patients with a diagnosis of HCC and not appropriate for curative or palliative treatments were followed and managed with supportive therapy. Cirrhosis was diagnosed by histological or clinical features and liver function was evaluated according to Child-Pugh score. The diagnosis of HCC was performed by Ultra-Sound guided biopsy or by multiphasic contrast-enhanced computed tomography or gadolinium-enhanced magnetic resonance imaging. Data were collected…

Oncologymedicine.medical_specialtyBrief ArticleHepatologybusiness.industryClinical courseCancerRetrospective cohort studymedicine.diseasedigestive system diseasesSurgeryNatural historyInternal medicineHepatocellular carcinomamedicinehepatocellular carcinoma survival natural historyStage (cooking)businessWorld Journal of Hepatology
researchProduct